2-methyl-3-o-tolyl-acrylic acid | 849831-36-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 2-methyl-3-o-tolyl-acrylic acid
• 英文别名: (E)-2-methyl-3-(o-tolyl)acrylic acid；o,α-Dimethyl-zimtsaeure；2-methyl-3t-o-tolyl-acrylic acid；2-Methyl-3t-o-tolyl-acrylsaeure；(2E)-2-Methyl-3-(2-methylphenyl)-2-propenoic acid；(E)-2-methyl-3-(2-methylphenyl)prop-2-enoic acid
• CAS: 849831-36-3
• 化学式: C₁₁H₁₂O₂
• 分子量: 176.215
• InChiKey: LUPFTDWCMOPSIR-VQHVLOKHSA-N

物化性质

• 熔点：
  108-110 °C
• 沸点：
  300.1±11.0 °C(Predicted)
• 密度：
  1.117±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-methyl-3-o-tolyl-acrylic acid 在 Pd-BaSO₄ 、 sodium carbonate 作用下， 生成 2-methyl-3-(o-tolyl)propanoic acid
  参考文献：
  名称：

  Hormonal control of a gene encoding a putative PDR5-like ABC transporter in periwinkle

  摘要：

  ATP binding cassette (ABC) transporters retain increasing attention since their implication in multidrug resistance has been demonstrated in several prokaryotic and eukaryotic cells. Many ARC proteins are known in various organisms but only few in higher plants. We report here on the characterization of a partial 955 bp clone (Cr-ABC1) isolated from a Catharanthus roseus cDNA library, which shows high homology (65% identity) with the TUR2 cDNA previously isolated from the water lens Spirodela polyrrhiza. Accumulation of Cr-ABC1 transcripts in cultured C. roseus cells was enhanced by cytokinin or methyl jasmonate addition to, or auxin suppression from the culture medium. In whole plants, the gene was mainly expressed in flowers.

  DOI：

  10.1080/12538078.2000.10515842
• 作为产物：
  描述：

  2-甲基苯甲醛 在 水 、 sodium hydride 、 potassium hydroxide 作用下， 以 四氢呋喃 、 乙醇 、 mineral oil 为溶剂， 反应 0.5h， 生成 2-methyl-3-o-tolyl-acrylic acid
  参考文献：
  名称：

  铜对极化烯烃的催化热力学异构化。

  摘要：

  报道了Cu（OAc）2 / rac -BINAP配合物在蓝光下催化α-和β-取代肉桂酸酯衍生物的反热力学异构化。恶唑烷酮模板的使用有利于铜催化剂与底物的络合，允许在简单而稳定的反应条件下以良好至优异的比率进行催化形成的生色团的E → Z异构化。还研究了基于生色团的瞬时形成的该过程的机理。

  DOI：

  10.1021/acs.orglett.0c02894

文献信息

• Asymmetric Hydrogenation of α,β-Unsaturated Carboxylic Acids Catalyzed by Ruthenium(II) Complexes of Spirobifluorene Diphosphine (SFDP) Ligands
  作者：Xu Cheng、Jian-Hua Xie、Sheng Li、Qi-Lin Zhou

  DOI：10.1002/adsc.200606065

  日期：2006.7

  The ruthenium diacetate complexes ligated by chiral spirobifluorene diphosphines (SFDP) were very effective catalysts for the asymmetric hydrogenation of tiglic acid derivatives and α-methylcinnamic acid derivatives with high activities and excellent enantioselectivities (up to 98 % ee). The α-aryloxybutenoic acids can also be hydrogenated by these catalysts to provide the corresponding saturated α-aryloxybutanoic

  由手性螺二芴二膦（SFDP）连接的二乙酸钌络合物是非常有效的催化剂，用于对酸衍生物和α-甲基肉桂酸衍生物进行不对称氢化，具有高活性和出色的对映选择性（最高98％ee）。这些催化剂还可以将α-芳氧基丁烯酸加氢，以提供相应的饱和α-芳氧基丁酸，以高收率（89-93％）和对映选择性（高达95％ee）提供。在该反应中，配体SFDP与对位上的甲基团P -苯基环，得到最好的结果。
• Catalytic Enantioselective Nazarov Cyclization
  作者：Anais Jolit、Cody F. Dickinson、Kei Kitamura、Patrick M. Walleser、Glenn P. A. Yap、Marcus A. Tius

  DOI：10.1002/ejoc.201701117

  日期：2017.11.2

  The detailed account of an asymmetric Nazarov cyclization that leads to α-hydroxycyclopentenones bearing either vicinal, all-carbon atom quaternary centers, or vicinal quaternary and tertiary centers is described. The all-aliphatic examples represent the greatest challenge as the dienone starting materials are not activated toward cyclization by an aryl group. The rational design and optimization of

  描述了不对称 Nazarov 环化的详细说明，该环化导致 α-羟基环戊烯酮带有邻位、全碳原子四级中心或邻位四级和三级中心。全脂肪族的例子代表了最大的挑战，因为二烯酮起始材料不会被芳基活化成环化。还描述了底物的合理设计和优化与手性布朗斯台德酸催化剂的优化以及完全取代的环戊烯酮产物的一系列非对映选择性转化。
• [EN] 3,4-SUBSTITUTED PYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] INHIBITEURS DE BÊTA-SÉCRÉTASE DE TYPE PYRROLIDINES 3,4-SUBSTITUÉES POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
  申请人：MERCK & CO INC

  公开号：WO2009078932A1

  公开（公告）日：2009-06-25

  The present invention is directed to 3,4-substituted pyrrolidine compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及式(I)的3,4-取代吡咯烷化合物，其为β-分泌酶酶抑制剂，可用于治疗涉及β-分泌酶酶的疾病，如阿尔茨海默病。该发明还涉及包含这些化合物的药物组合物，以及这些化合物和组合物在治疗涉及β-分泌酶酶的疾病中的用途。
• 3,4-SUBSTITUTED PYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
  申请人：Stachel Shawn J.

  公开号：US20100280009A1

  公开（公告）日：2010-11-04

  The present invention is directed to 3,4-substituted pyrrolidine compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及公式（I）的3,4-取代吡咯烷化合物，其为β-分泌酶酶的抑制剂，并且在治疗β-分泌酶酶参与的疾病，例如阿尔茨海默病中有用。本发明还涉及包含这些化合物的药物组合物以及在治疗β-分泌酶酶参与的这些疾病中使用这些化合物和组合物的用途。
• PHENYLALKYL SULFAMATE COMPOUND AND MUSCLE RELAXANT COMPOSITION COMPRISING THE SAME
  申请人：BIO-PHARM SOLUTIONS CO., LTD.

  公开号：US20150266848A1

  公开（公告）日：2015-09-24

  The present invention relates to novel phenylalkyl sulfamate compounds, a method for preventing or treating a disease associated with muscle spasm. The present invention ensures the enhancement of muscle relaxation activity essential for alleviation of muscle spasm, such that it is promising for preventing or treating various diseases associated with muscle spasm.

  本发明涉及一种新型的苯基烷基磺酰胺化合物，以及一种预防或治疗与肌肉痉挛有关的疾病的方法。本发明确保增强肌肉松弛活性，这对于缓解肌肉痉挛至关重要，因此本发明有望预防或治疗与肌肉痉挛有关的各种疾病。